Methotrexate attenuates the Th17/IL-17 levels in peripheral blood mononuclear cells from healthy individuals and RA patients

Rheumatology International

Volumn 32, Issue 8, 2012, Pages 2415-2422

  Li, Yanshan ^a   Jiang, Lindi ^a   Zhang, Si ^a   Yin, Lianhua ^a   Ma, Lili ^a   He, Dongyi ^b   Shen, Jie ^b  

^a FUDAN UNIVERSITY   (China)

^b Guanghua Hospital   (China)

Author keywords

Arthritis; Il 17; Methotrexate; Rheumatoid

Indexed keywords

CD4 ANTIGEN; INTERLEUKIN 17; MESSENGER RNA; METHOTREXATE; MONOCLONAL ANTIBODY CD28; MONOCLONAL ANTIBODY CD3;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DRUG EFFECT; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; MALE; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; RHEUMATOID ARTHRITIS; TH17 CELL;

ADULT; AGED; ANTIBODIES, MONOCLONAL; ANTIGENS, CD28; ANTIGENS, CD3; ANTIRHEUMATIC AGENTS; ARTHRITIS, RHEUMATOID; CASE-CONTROL STUDIES; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; FLOW CYTOMETRY; HUMANS; INTERLEUKIN-17; MALE; METHOTREXATE; MIDDLE AGED; RNA, MESSENGER; TH17 CELLS; YOUNG ADULT;

EID: 84866249315     PISSN: 01728172     EISSN: 1437160X     Source Type: Journal    
DOI: 10.1007/s00296-011-1867-1     Document Type: Article

References (32)

1. Andersson AK, Li C, Brennan FM (2008) Recent developments in the immunobiology of rheumatoid arthritis. Arthritis Res Ther 10(2):204. doi:10.1186/ar2370
2. Salliot C, van der Heijde D (2009) Long-term safety of methotrexate monotherapy in patients with rheumatoid arthritis: a systematic literature research. Ann Rheum Dis 68(7):1100-1104. doi:10.1136/ard.2008.093690
3. Visser K, Katchamart W, Loza E, Martinez-Lopez JA, Salliot C, Trudeau J et al (2009) Multinational evidence-based recommendations for the use of methotrexate in rheumatic disorders with a focus on rheumatoid arthritis: integrating systematic literature research and expert opinion of a broad international panel of rheumatologists in the 3E Initiative. Ann Rheum Dis 68(7):1086-1093. doi:10.1136/ard.2008.094474
4. Chan ES, Cronstein BN (2002) Molecular action of methotrexate in inflammatory diseases. Arthritis Res 4(4):266-273
5. Cronstein BN (2005) Low-dose methotrexate: a mainstay in the treatment of rheumatoid arthritis. Pharmacol Rev 57(2):163-172. doi:10.1124/pr.57.2.3
6. Smoleńska Z, Kaznowska Z, Zarówny D, Simmonds HA, Smoleński RT (1999) Effect of methotrexate on blood purine and pyrimidine levels in patients with rheumatoid arthritis. Rheumatology (Oxford) 38(10):997-1002
7. Budzik GP, Colletti LM, Faltynek CR (2000) Effects of methotrexate on nucleotide pools in normal human T cells and the CEM T cell line. Life Sci 66(23):2297-2307
8. Mello SB, Barros DM, Silva AS, Laurindo IM, Novaes GS (2000) Methotrexate as a preferential cyclooxygenase 2 inhibitor in whole blood of patients with rheumatoid arthritis. Rheumatology (Oxford) 39(5):533-536
9. Montesinos MC, Desai A, Delano D, Chen JF, Fink JS, Jacobson MA et al (2003) Adenosine A2A or A3 receptors are required for inhibition of inflammation by methotrexate and its analog MX-68. Arthritis Rheum 48(1):240-247. doi:10.1002/art.10712
10. Phillips DC, Woollard KJ, Griffiths HR (2003) The anti-inflammatory actions of methotrexate are critically dependent upon the production of reactive oxygen species. Br J Pharmacol 138(3): 501-511
11. Johnston A, Gudjonsson JE, Sigmundsdottir H, Ludviksson BR, Valdimarsson H (2005) The anti-inflammatory action of methotrexate is not mediated by lymphocyte apoptosis, but by the suppression of activation and adhesion molecules. Clin Immunol 114(2):154-163. doi:10.1016/j.clim.2004.09.001
12. Aggarwal A, Misra R (2003) Methotrexate inhibits interleukin-6 production in patients with juvenile rheumatoid arthritis. Rheumatol Int 23(3):134-137. doi:10.1007/s00296-002-0267-y
13. Gerards AH, de Lathouder S, de Groot ER, Dijkmans BA, Aarden LA (2003) Inhibition of cytokine production by methotrexate. Studies in healthy volunteers and patients with rheumatoid arthritis. Rheumatology 42(10):1189-1196. doi:10.1093/rheumatology/keg323
14. Kim KW, Cho ML, Park MK, Yoon CH, Park SH, Lee SH et al (2005) Increased interleukin-17 production via a phosphoinositide 3-kinase/Akt and nuclear factor kappaB-dependent pathway in patients with rheumatoid arthritis. Arthritis Res Ther 7(1):R139-R148. doi:10.1186/ar1470
15. Kohno M, Tsutsumi A, Matsui H, Sugihara M, Suzuki T, Mamura M et al (2008) Interleukin-17 gene expression in patients with rheumatoid arthritis. Mod Rheumatol 18(1):15-22. doi:10.1007/s10165-007-0015-y
16. Peck A, Mellins ED (2009) Breaking old paradigms: Th17 cells in autoimmune arthritis. Clin Immunol 132(3):295-304. doi: 10.1016/j.clim.2009.03. 522
17. Park H, Li Z, Yang XO, Chang SH, Nurieva R, Wang YH et al (2005) A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17. Nat Immunol 6(11): 1133-1141. doi:10.1038/ni1261
18. Kotake S, Udagawa N, Takahashi N, Matsuzaki K, Itoh K, Ishiyama S et al (1999) IL-17 in synovial fluids from patients with rheumatoid arthritis is a potent stimulator of osteoclastogenesis. J Clin Invest 103(9):1345-1352. doi:10.1172/JCI5703
19. Zrioual S, Ecochard R, Tournadre A, Lenief V, Cazalis MA, Miossec P (2009) Genome-wide comparison between IL-17A-and IL-17F-induced effects in human rheumatoid arthritis synoviocytes. J Immunol 182(5):3112-3120. doi:10.4049/jimmunol.0801967
20. Lubberts E, Koenders MI, Oppers-Walgreen B, van den Bersselaar L, Coenen-de Roo CJ, Joosten LA et al (2004) Treatment with a neutralizing anti-murine interleukin-17 antibody after the onset of collagen-induced arthritis reduces joint inflammation, cartilage destruction, and bone erosion. Arthritis Rheum 50(2): 650-659. doi:10.1002/art.20001
21. van den Berg WB, Miossec P (2009) IL-17 as a future therapeutic target for rheumatoid arthritis. Nat Rev Rheumatol 5(10):549-553. doi:10.1038/nrrheum. 2009.179
22. Nakae S, Nambu A, Sudo K, Iwakura Y (2003) Suppression of immune induction of collagen-induced arthritis in IL-17-deficient mice. J Immunol 171(11):6173-6177
23. Fujimoto M, Serada S, Mihara M, Uchiyama Y, Yoshida H, Koike N et al (2008) Interleukin-6 blockade suppresses autoimmune arthritis in mice by the inhibition of inflammatory Th17 responses. Arthritis Rheum 58(12):3710-3719. doi:10.1002/art.24126
24. Zhang Z, Zhao P, Li A, Lv X, Gao Y, Sun H et al (2009) Effects of methotrexate on plasma cytokines and cardiac remodeling and function in postmyocarditis rats. Mediators Inflamm 389720(1-9). doi:10.1155/2009/389720
25. Shin HC, Benbernou N, Fekkar H, Esnault S, Guenounou M (1998) Regulation of IL-17, IFN-gamma and IL-10 in human CD8(+) T cells by cyclic AMP-dependent signal transduction pathway. Cytokine 10(11):841-850
26. Kageyama Y, Kobayashi H, Kato N (2009) Infliximab treatment reduces the serum levels of interleukin-23 in patients with rheumatoid arthritis. Mod Rheumatol 19(6):657-662. doi: 10.1007/s10165-009-0217-6
27. Yue C, You X, Zhao L, Wang H, Tang F, Zhang F et al (2010) The effects of adalimumab and methotrexate treatment on peripheral Th17 cells and IL-17/IL-6 secretion in rheumatoid arthritis patients. Rheumatol Int 30(12):1553-1557. doi:10.1007/s00296-009-1179-x
28. Hider SL, Silman AJ, Thomson W, Lunt M, Bunn D, Symmons DP (2009) Can clinical factors at presentation be used to predict outcome of treatment with methotrexate in patients with early inflammatory polyarthritis? Ann Rheum Dis 68(1):57-62. doi: 10.1136/ard.2008.088237
29. Drouin J, Haraoui B, 3e Initiative Group (2010) Predictors of clinical response and radiographic progression in patients with rheumatoid arthritis treated with methotrexate monotherapy. J Rheumatol 37(7):1405-1410. doi:10.3899/jrheum.090838
30. Wessels JA, van der Kooij SM, le Cessie S, Kievit W, Barerra P, Allaart CF et al (2007) A clinical pharmacogenetic model to predict the efficacy of methotrexate monotherapy in recent-onset rheumatoid arthritis. Arthritis Rheum 56(6):1765-1775. doi: 10.1002/art.22640
31. Mewar D, Wilson AG (2006) Autoantibodies in rheumatoid arthritis: a review. Biomed Pharmacother 60(10):648-655. doi: 10.1016/j.biopha.2006.09.002
32. Tighe H, Chen PP, Tucker R, Kipps TJ, Roudier J, Jirik FR et al (1993) Function of B cells expressing a human immunoglobulin M rheumatoid factor autoantibody in transgenic mice. J Exp Med 177(1):109-118